Strides Pharma Science has informed that it enclosed the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2022, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The Board Meeting commenced at 12:45 hrs and concluded at 14:30 hrs.
The above information is a part of company’s filings submitted to BSE.
